Three patients are described in whom haemodynamic collapse and acute renal failure occurred following intercurrent gastrointestinal fluid loss during treatment with an angiotensin converting-enzyme inhibitor. The possible consequences of blockade of the formation of angiotensin II during fluid loss are discussed.
Introduction
Angiotensin converting-enzyme (ACE) inhibitors are an important recent addition to the therapeutic armamentarium for the treatment ofhypertension and cardiac failure. Recent reviews have forecast their wider use in both conditions."2 The potentially severe hypotensive effect ofthese agents in some patients who may be salt and water depleted from concomitant diuretic therapy is well recognized.3 Less A 58 year old man was admitted because of nausea, fatigue and postural dizziness. He was known to have longstanding left ventricular dysfunction following mitral valve replacement for rheumatic heart disease. His condition had been stable for two months on treatment with enalapril 20 mg and bumetanide 15 mg daily and his weight had remained steady over this period. For one week before admission he had three to four episodes of diarrhoea daily.
On examination the patient was poorly perfused and had atrial fibrillation and pulse of 56/minute. The venous pressure was low and the blood pressure was 80/50 mmHg compared to 120/80 mmHg at discharge from a recent admission for introduction of enalapril. A chest radiograph showed cardiomegaly and clear lung fields.
This patient was also felt to be hypovolaemic as a result of gastrointestinal fluid loss aggravated by concurrent treatment with an ACE inhibitor and diuretic. These drugs were withdrawn and 8 litres of intravenous saline administered over the next 72 hours. The patient, however, remained hypotensive and oliguric and his urea and creatinine rose from 35.5 mmol/l and 452 ymol/l on admission to 41.6 mmol/I and 637 pmol/I respectively. A diuresis ensued after some days, in keeping with the diagnosis of acute tubular necrosis. The cause of this patient's diarrhoea was not established but it did not recur. Enalapril, and subsequently a diuretic, were cautiously restarted and the patient was finally discharged three weeks after admission on his original medication with a urea of 5.1 mmol/l and creatinine of 117 pmol/l. He remains well on follow-up with normal blood chemistry.
Discussion
In these three patients taking ACE inhibitors, unexpected salt and water loss, in the form ofdiarrhoea and vomiting, resulted in life-threatening hypovolaemia, hypotension and renal impairment. The severity in each case was almost certainly due, in part, to the ability ofthese drugs to interfere with all the important homeostatic responses to such extracellular fluid volume loss.4 Arterial tone, and thus maintenance of blood pressure, depends, partly, on the direct vasoconstrictor action of angiotensin II.4 '5 Autoregulation of intra-renal blood flow, and therefore glomerular filtration, also depends on angiotensin 11.267 These actions are particularly important during sodium loss.4'5 Two of our patients had cardiac failure which in itself causes reduced renal blood flow. In such patients significant hypovolaemia might more quickly produce a critical reduction in renal perfusion and glomerular filtration in the absence of angiotensin I.8 These two patients were also 'primed' by prior diuretic treatment, making them less resistant to additional sodium loss. In the third patient these considerations would not seem to apply and it would appear that, even in patients with adequate circulatory reserve, blood pressure and renal perfusion cannot be maintained in the face offluid loss without angiotensin II. Because of concurrent treatment with an ACE inhibitor none of these angiotensin II-dependent adaptations to fluid loss could, of course, occur. Furthermore, enhancement ofproximal tubular sodium reabsorption by angiotension II and stimulation of aldosterone secretion would also have been blocked by these drugs. 4 Thus two further compensatory responses were certainly attenuated in our patients. Finally, both captopril and enalapril are, to a large extent, renally excreted and renal impairment will result in a vicious cycle further exaggerating these effects.9"l0 There may be other important, though less well understood, actions ofthese drugs directly, or indirectly, on the antidiuretic hormone and autonomic-catecholamine responses to the fluid loss. 4 It is therefore not surprising that an insult such as diarrhoea and vomiting can cause such a profound haemodynamic upset in the presence of pharmacological ACE inhibition, especially in patients with diminished circulatory reserve, as in two of these three cases. This danger, however, does not appear to be well recognized and needs to be stressed. This problem must be anticipated as prompt measures to discontinue these drugs and institute immediate and adequate salt and water replacement are necessary to prevent a potentially very serious outcome. 
